To clarify the natural course of gold nephropathy and thereby facilitate its clinical management 21 patients with rheumatoid arhritis who developed proteinuria during treatment with intramuscular sodium aurothiomalate were studied in detail throughout their renal illnesses. Renal biopsies were performed, and creatinine clearance and protein were measured serially for 60 months (range 16-130 months). Ten patients developed proteinuria after six months' treatment, 15 after 12 months, and 18 after 24 months. When treatment wa stopped the proteinuri reached a median peak of 2-1 g/day (range 0 7-30*7 g/day) at two months (range 1-13 months) before resolving spontaneously, in eight patients by six months, in 13 by 12 months, and in 18 by 24 months. All patients were free ofproteinuria by 39 months, the median duration being 11 months. The median first and last measurements of creatinine clearance showed no significant change (77 mI/minute and 59 mI/minute, respectively), and no patient died from or needed treatment for renal failure. HIA-B8 or DR3 alloantigens, or both, were identified in seven patients. Renal biopsy specimens showed membranous glomerulonephritis in 15 patients, a minimal change nephropathy in two, mesangial electron dense deposits in two, and no appreciable glomerular changes in two.
Introduction
Gold has been accepted as an effective second line treatment for rheumatoid arthritis, but complications are common and include renal damage in 2-10% of patients. This presents as proteinuria of widely varying severity (0-439-0 g/day) and causes otherwise successful treatment to be stopped. ' Gold nephropathy has been observed at all ages (2-73 years) and with all gold preparations, whether given parenterally or orally.'2 It may develop at any time from two weeks (total dose 10 mg) to six years (6000 mg) after the start of treatmentM and occurs particularly in patients with seronegative rheumatoid arthritis.467 The proteinuria resolves spontaneously in some patients when the gold is stopped,68-10 but the time course is not known; in other patients it persists6 1 or responds only to high doses ofcorticosteroids.3 6 " 10 12 1' Limited data indicate that renal function usually remains normal or is only slightly impaired' 1013 although severe impairment has been reported" 12 and serial and long term measurements have not been made. Recent immunogenetic and metabolic studies indicated that gold nephropathy is more likely to occur in patients with rheumatoid arthritis positive for the HLA-B8 or HLA-DR3 antigen4 15 or who have a low capacity for the sulphoxidation of carbcisteine."6 Renal biopsy usually showed membranous glomerulonephritis3-6 10 12 13 but not invariably. ' 4913 Current knowledge of gold nephropathy is based on case reports and reports ofsmall series ofpatients, none ofwhich have contained the serial clinical data that are essential to an understanding of the natural course of the disease. We studied 21 patients with rheumatoid arthritis and gold nephropathy in detail throughout the whole of their renal illnesses to try to provide these data.
Patients and methods
Between October 1974 and August 1983, 21 patients (10 men and 11 women) with rheumatoid arthritis who had not previously had pro-745 teinuria were referred-with proteinuria that had developed while they were receiving treatment with sodium-aurothiomalate intramuscularly. All patients fulfilled the American Rheumatism Association's criteria for the diagnosis of rheumatoid arthritis, and in 19 circulating IgM rheumatoid factor was present. The gold had been given as a standard regimen, a 10 mg test dose having been followed by 50 mg at weekly intervals until a satisfactory clinical response had been achieved. Thereafter 50 mg injections had been given at fortnightly or monthly intervals to maintain the remission. Results Table I shows details of the patients and their treatment. The renal biopsies were performed three months (interquartile range 1-6, range 0-1-16-0 months) after the treatment had been stopped. Table II shows the time of onset of proteinuria (between two weeks and 39 months) after the start of treatment with gold. The peak incidence occurred between four and six months of treatment, when eight patients presented. Overall, 10, 15, and 18 patients had presented by six, 12, and 24 months, respectively.
PROTEINURIA
The severity of the proteinuria varied greatly (0-7-30-7 g/day) and was not associated with the duration of treatment or the total dose of gold received. Table III shows the median initial and maximum measurements of proteinuria. In 10 patients the initial measurement was also the maximum, while in 11 the proteinuria increased for four months (interquartile range 3-11, range 1-13 months) after treatment was stopped. In eight patients the proteinuria was within the range indicating the nephrotic syndrome (median 5-3 g/day; interquartile range 3-6-15-6, range 3-6-30-7 g/day) and persisted for a median period of 45 months (interquartile range 2-11, range 2-18 months). In all cases the nephrotic syndrome was controlled with a diet high in protein and low in salt and by treatment. with diuretics.
Proteinuria persisted for 29, 30, and 39 months, respectively, 'in three patients, though was less severe. The median duration of proteinuria was 11 months (interquartile range 4-19, range 1-39 months), and in all 21 patients it resolved completely and did not recur. At six, 12, and 24 months after gold treatment was stopped the proteinuria had resolved in eight, 13, and 18 patients, respectively, and all were free by 39 months (fig 1) .
RENAL FUNCTION
The median initial and last measurements of creatinine clearance in all 21 patients were 77 ml/min (interquartile range 60-108, range 18-185 m/min) and 59 ml/min (interquartile range 42-86, range 33-134 ml/min) with an interval of 60 months (interquartile range 39-85, range 16-130 months); the deterioration was not significant. Figure 2 shows the creatinine clearances measured in the first and second six months and within two year periods thereafter.' Only three patients had initial creatinine clearances of less than 50 ml/min (18, 41, and 44 ml/min), and all improved during the follow up period (33, 50, and 48 ml/min, respectively). No patient died fromor needed treatment for chronic renal failure. We have confirmed previous reports that the severity and nonths) duration of the proteinuria vary greatly,36 " and there was no correlation with the duration of treatment or the total dose gold stopped.
received.3 In all cases the proteinuria resolved completely after treatment was stopped: though it usually resolved within two years, it occasionally increased for up to 13 months and persisted for 39 months. These data indicate that previous reports of apparently irreversible proteinuria3 61013 were premature as the follow up period did not exceed 26 months in any series.
The creatinine clearance measurements reported in this study are the first long term serial measurements of renal function in gold nephropathy and indicate that significant deterioration did not occur. Even when renal function was severely impaired at presentation improvement occurred and was maintained when treatment with gold was stopped.
These results show clearly that in patients with proteinuria treatment with gold should be stopped and renal function and proteinuria monitored at intervals of one to three months until the proteinuria has resolved. The nephrotic syndrome that develops in one third of those affected can be controlled with a diet high in protein and low in salt and by treatment with diuretics. Treatment with high doses of corticosteroids, which has been used previously,36'0"13 is not indicated as it is unnecessary and potentially hazardous, and there is no evidence that it shortens the duration of the proteinuria or leads to a more rapid or more complete resolution of the renal lesion. Referral for renal biopsy is necessary only if proteinuria within the range indicating the nephrotic syndrome (>3 g/day) persists for more than one year, if less severe proteinuria persists for more than three years, if renal function deteriorates appreciably, or if there is concern that a second disease (usually amyloid) may be present. 5
Membranous glomerulonephritis is the renal lesion most " >85 commonly associated with gold treatment '2 and was seen in 15 patients (71%) in the present series. In two of the six patients who did not have this lesion the renal biopsy specimen showed a minimal er treatment change nephropathy, which has been reported previously in interquartile association with treatment with gold.40 In a further two patients the presence of mesangial electron dense-deposits indicated that a mesangial lesion was the cause of the proteinuria. The remaining two patients who had normal glomeruli on immunofluorescence scopy and yielded and electron microscopy both had only low grade proteinuria complement with (<1 glday), which may have been of tubular rather than glomerular :tensive fusion of origin. ich, in the absence Thus it seems that gold nephropathy encompasses several types 3ial electron dense of renal damage due to different pathogenetic mechanisms. re seen, and in the In patients with rheumatoid arthritis not receiving gold (or peniciltected. famine) there is an increased incidence of both membranous glomerulonephritis3 17 and mesangial changes4 11 due to deposition of immune complexes in specific regions of the glomerulus. Treatment with gold may modify the immune system, thereby aggravating the persistence and deposition of existing "rheumatoid" Is identified the immune complexes, causing an increased incidence of membranous Ald nephropathy glomerulonephritis, and potentiating the mesangial lesions of the 747 rheumatoid arthritis. It may intensify the glomerular injury mediated by T cells, leading to a minimal change nephropathy, and by a direct nephrotoxic action cause tubular proteinuria and release the renal tubuloepithelial antigen that may be of particular importance in the immunopathogenesis of membranous glomerulonephritis. '7 Thus treatment with gold may cause renal damage by mechanisms that are not a primary part of rheumatoid disease as well as by potentiating existing immune abnormalities. Although these data were from patients receiving parenteral sodium aurothiomalate, they may also be relevant to patients with renal damage caused by any gold preparation, parenteral or oral.'2 As treatment with gold is effective and widely used for active and progressive rheumatoid disease gold nephropathy_will continue to occur and a detailed knowledge of the natural course of the condition is essential for the correct management of affected patients. 
ONE HUNDRED YEARS AGO
Since the publication ofour article on the above subject on Saturday last, we have been at pains to obtain the best information on the point at issue, from officers of standing and experience in the combatant as well as in the departmental ranks of the army. Far from having any reason to believe that the note of alarm we sounded was false, we are satisfied that it was not an hour too soon to call attention to what we are constrained to believe was an intended blow at the status of our professional brethren in the army. The medical staffdo not need any exposition ofthe case at our hands; they have to wear the shoe, and they know where it pinches. It is to the profession in civil life that we address our remarks to-day, more particularly to men oflight and leading in our ranks, to the professors and teachers in our universities and medical schools in the great centres of education throughout the kingdom, and to the young men whose professional education is sufficiently advanced to cause them to turn over in their minds the important question ofa career.
What we have to warn them against is the danger ofhaving dust thrown in their eyes, by delusive official "explanations," either in the House of Commons in answer to questions, or by memoranda cleverly worded with the intention of misleading civilians who so far interest themselves in the matter as to seek for information either from War Office or Horse Guards officials.
There are, or were, three kinds of rank recognised in the army, namely, substantive, honorary, and relative rank; the last was the recognised rank of army medical officers. It was this that gave them all their privileges and precedence, and, so far as it went, their position in the army. That rank is abolished, and the outcome is they have now no rank at all. Mr Stanhope is, as lawyers say, "instructed" to say that it makes no difference, that the position ofarmy medical officers is not changed, that their privileges remain, and so forth, and we believe that Mr Stanhope is honest and simple enough to believe what he is told, and, parrot-like, to repeat in the House.
But this is not how the matter is regarded in the army. It may be true a surgeon will get his quarters and his cabin in a transport as he did before, but rank in the army he has none, and so long as this is the case he will be made to feel it every hour of his life. The officers who pay and feed the army have recognised titular rank. They are styled honorary Captains, Majors, Lieut.-Colonels, and so on, according to their grade, although it is as notorious as the sun at noonday that they do not run a tenth part of the risks-the honourable risks of war-that the surgeons of the army do from battle injuries and the diseases incident to campaigns. Do our readers doubt this? Let them look at the long list of young surgeons, hardly in their prime, who laid down their lives in our late wars in Afghanistan, in South Africa, in Egypt, and the Soudan, a list which we place before our readers in another page. We should like to know how many paymasters and commissariat officers lost their lives in battle, or died worn out by the night and day work offield and camp service? Which of them, like Shepherd at Isandlana, when that pitiful massacre was nearly over, dismounted from his horse, in answer to the appeal of a wounded soldier, and, died like a brave man as he was, while binding up the wounds of his humble comrade? Which of them at the miserablefiasco of Engoga went during that long day under fire, as another surgeon did, from one wounded man to another, as calmly as he would have done in the wards of Netley Hospital, and a few days afterwards died of his wounds on Majuba Hill? Not to speak of his noble brother officer, who, when all who were not killed or wounded on that hill-the very name of which brings a blush of shame on every Englishman's face-had left, remained with his wounded, and when about to die from a mortal wound, gathered his remaining energies and fast ebbing strength, and gave a hypodermic injection of morphine to a man screanming under the torture of a wound. This is a matter that demands plain speaking; and, without any wish to hurt the feelings of any one, we must illustrate our meaning by an example. In the Gazette of Friday, February 25th, an officer is retired with the rank of Major. This meritorious gentleman began his career as a private in the Hospital Corps. The late Professor Parkes took him into his laboratory, as a laboratory assistant, and never rested until he obtained for him the rank of Sergeant; from this he was promoted in the Army Hospital Corps, and, we believe, under some of the many changes of late years, was attached to the Commissariat. On retirement, he carried with him the honorary rank of Major. Mark this: If Dr Parkes had remained in the army, and lived to see the present state of affairs, this Major, in military society, would have been the superior in rank to one ofthe most illustrious men the medical profession in England has ever produced.
We wish it to be distinctly understood that army medical officers do not covet military titles. What they have a right to demand is, that a Royal Warrant shall be published in which their rank shall be defined, their professional titles being the equivalents of recognised military grades, known and seen of all men-not, as now, the nominal possessors of "privileges" which give them no status that is recognisable. Until this is done, we warn the younger members of our profession that the medical ranks of the army is no longer a place for gentlemen.
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